-
An experimental vaccine could be on the market for ovarian-cancer patients as soon as 2022, according to the Jacksonville-based company that makes it....
-
The generic form of the blockbuster cancer drug is being shipped to pharmacies. The generic is likely to cost 30 percent less than the brand-name version, but Gleevec's price doubled in recent years.
-
Cancer patients shopping on federal and state insurance marketplaces often find it difficult to determine whether their drugs are covered and how much…
-
Many cancer treatments have a dark side — they can damage the heart. New research suggests this risk might be lowered in women with breast tumors if they…